Skip to Content
Jump to the top of the page

William Blair Thinking

  • The Quarterly Rx: Q1 2026 U.S. Biopharma Recap

    The U.S. biopharma sector demonstrated resilience in the first quarter of 2026, building on its recovery despite geopolitical and macroeconomic uncertainty.

    Read more
  • Monthly Macro: Geopolitical Shock, Inflation Risks, and a Market on Edge

    William Blair macro analyst Richard de Chazal unpacks the market implications of the U.S.–Iran conflict, discussing how the war is reshaping inflation and growth risks and challenging central banks’ playbooks, and why markets may be underpricing the possibility of a more prolonged disruption. Richard also touches on emerging stress in private credit beneath the surface.

    Read more
  • The “Software Apocalypse” Narrative: Fact or Fiction?

    Shares of mega-cap software companies recently fell amid fears that agentic AI could replace them entirely. Here’s why those concerns may be overblown and how to spot the real AI winners.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • WD-40 Company: Initiation of Research Coverage

    William Blair initiated research coverage of WD-40 Company (WDFC $206.18), a leading innovator, marketer, and seller of products that solve problems for consumers in homes and users in workshops and factories around the world.

    Read more
  • William Blair Recognized in "Where You Work Matters" List of Top Employers

    William Blair was included in the 2026 "Where You Work Matters" list as a Platinum Employer. This independent rating uses objective data to assess workplace quality across U.S. employers.

    Read more
  • MiniMed Group, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of MiniMed Group, Inc. (MMED $14.47), a global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures